// App-Quantinova.ai

399 : Targeting STAT5 in Leukemia Through Inhibition of Bromodomain Proteins

Researchers

Presenter

  • Sarah Walker

Principal Investigators

  • Erik Nelson

  • Robert Cirulli

  • Michael Xiang

  • Jun Qi

  • James E Bradner

  • David Frank

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Chronic Myelogenous Leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved